3 Shops Await Word on Novartis' Elidel

Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.

NEW YORK Three agencies are awaiting a decision in the review for creative duties on Novartis’ Elidel account, sources said.

The East Hanover, N.J., client in September heard pitches from the incumbent, WPP Group’s Quantum Group in Parsippany, N.J.; and Omnicom Group’s Merkley Newman Harty & Partners and Interpublic Group’s Deutsch, both New York, sources said. A decision is expected in two weeks.

Quantum launched the first ad campaign for the prescription skin cream to treat eczema in March.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in